most citedTreatment Effect Estimation in Causal Survival Analysis: Practical Recommendations

2 citations · 2 across the 5 of their papers we have counts for

collaborators

7 papers

stat.ME2026

A Bayesian Approach to Causal Cure Models

Emma Torrini, Maïlis Amico, Nicolas Molinari +1

Time-to-event data often include individuals who will never experience the failure event, and are therefore considered cured. In such settings, frequently encountered in clinical r…

stat.ME2026

Causal Perspectives on Network Meta-Analysis

Ahmed Boughdiri, Francisco Andrade, Clément Berenfeld +1

Pairwise and network meta-analyses occupy the highest tier of evidence-based medicine and routinely inform clinical guidelines and healthcare decision-making. Current approaches ty…

cs.LG2026

Causal Evaluation of Membership Inference Attacks

Mathieu Even, Clément Berenfeld, Linus Bleistein +3

Membership Inference Attacks (MIAs) aim to distinguish training points (members) from unseen data (non-members), and are widely used to quantify memorization and assess privacy ris…

stat.ME2026

Estimating treatment duration effects via clone-censor-weight: a breast cancer case study

Charlotte Voinot, Noémie Simon-Tillaux, Emma Torrini +4

In this work, we study the estimation of treatment duration effects in observational survival data, where treatment and covariate histories evolve over time and longer observed dur…

stat.ME2026

Causal Meta-Analysis: Rethinking the Foundations of Evidence-Based Medicine

Clément Berenfeld, Ahmed Boughdiri, Bénédicte Colnet +5

Meta-analysis, by synthesizing effect estimates from multiple studies conducted in diverse settings, stands at the top of the evidence hierarchy in clinical research. Yet, conventi…

stat.ME20262 cited

Treatment Effect Estimation in Causal Survival Analysis: Practical Recommendations

Charlotte Voinot, Clément Berenfeld, Imke Mayer +2

The restricted mean survival time (RMST) difference offers an interpretable causal contrast to estimate the treatment effect for time-to-event outcomes, yet a wide range of availab…